DMTsMSrelapsing multiple sclerosisSP
…ssed since the initial approval of disease-modifying therapies (DMTs). Ongoing discussion is focused on fundamental aspects of the d…
4articles mentioning drugs
5drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: DMTs ×
DMTs
This drug is selected. Its supporting articles are shown below.
Articles mentioning DMTs
4 articles · page 1 of 1PIRADMTsLate-onset multiple sclerosisLOMSmoderate–high-efficacy DMTs
… median of 4.43 years, with most events (83.6%) attributable to PIRA. The HR for time to CDP was 0.78 (p=0.08) and RAW was 0.69 (p=0…
DMTsParkinson’s Disease
…nd cost-effectiveness of potential disease-modifying therapies (DMTs) compared with a shared placebo on the rate of PD progression.M…
DMTsDMTsMultiple sclerosisMSNational Hospital of Neurology and NeurosurgeryUniversity College London Hospital NHS Trust
…ncluding the high costs of disease-modifying treatments (DMTs). DMTs have substantially reduced the risk of relapse and moderately r…